S1 Fig -
figure
posted on 2024-09-25, 17:27 authored by Issei Saeki, Shigeo Shimose, Tetsu Tomonari, Takanori Ito, Joji Tani, Yasuto Takeuchi, Naoki Yoshioka, Takehito Naito, Mamiko Takeuchi, Satoru Kakizaki, Takeshi Hatanaka, Kyo Sasaki, Tetsuya Yasunaka, Masahiro Sakata, Hideki Iwamoto, Satoshi Itano, Tomotake Shirono, Norikazu Tanabe, Takafumi Yamamoto, Yuki Kanayama, Atsushi Naganuma, Sohji Nishina, Motoyuki Otsuka, Hideki Kobara, Hiroki Kawashima, Tetsuji Takayama, Takumi Kawaguchi, Takahiro Yamasaki, Taro TakamiA. Waterfall plot of change in AFP at 4 weeks. B. Waterfall plot of change in DCP at 4 weeks.
(TIF)
History
Usage metrics
Categories
Keywords
unresectable hepatocellular carcinomaodds ratio 6odds ratio 3odds ratio 11multivariable analysis showedmultivariable analysis identifieddurvalumab plus tremelimumabaid early decisionsince sequential therapyline therapy recommendeddiv >< ppatients without afpbaseline afp levelhcc receiving durvasystemic therapy≥ 10two stepstwo groupstumor markerstreme therapystudy demonstratedstudy aimedsignificantly longersignificantly highersignificant differencesecond stepretrospectively enrolledreceived durvapredictors contributingpredictive biomarkerspredictive abilityp multicenter studymaking regardinginput factorsindependent predictorsimproving prognosishcc ).free survivalcombined immunotherapycarboxy prothrombinafp response5 %.5 %,400 ng4 weeks2 vs110 patients011 ),
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC